Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells
Latika Singh, Eric S. Muise, Anannya Bhattacharya, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 4, pp. 702-716
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 58
Monocytes in Tumorigenesis and Tumor Immunotherapy
Xiaodie Chen, Yunqing Li, Houjun Xia, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1673-1673
Open Access | Times Cited: 24
Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors
Yiting Wang, Yufan Sun, Shouyan Deng, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101374-101374
Open Access | Times Cited: 12
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
Zhiqing Xiang, Xiangli Yin, Leiyan Wei, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 8
Cooperation between inhibitory immune checkpoints of senescent cells with immunosuppressive network to promote immunosenescence and the aging process
Antero Salminen
Ageing Research Reviews (2025), pp. 102694-102694
Open Access | Times Cited: 1
The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells
Kevin J. Paavola, Julie M. Roda, Vicky Y. Lin, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 11, pp. 1283-1297
Open Access | Times Cited: 41
The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells
Xiaoyan Zhang, Meng Zhang, Hui Sun, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 7
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Mi Deng, Heyu Chen, Xiaoye Liu, et al.
Antibody Therapeutics (2021) Vol. 4, Iss. 1, pp. 16-33
Open Access | Times Cited: 34
Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
Guangshun Sun, Hanyuan Liu, Jie Zhao, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005655-e005655
Open Access | Times Cited: 22
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial
Kohei Shitara, Maria Di Bartolomeo, Mario Mandalà, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006920-e006920
Open Access | Times Cited: 14
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function
Carlo P. Ramil, Handan Xiang, Peng Zhang, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
Hongying Wang, Lei Wang, Huiwen Luan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models
Hongying Wang, Shuhao Ji, Jiashen Zhang, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 755, pp. 151536-151536
Closed Access
Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation
Christopher Papayannakos, Mohd Israr, James A. DeVoti, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy
Calvin D. De Louche, Ali Roghanian
JCI Insight (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 21
LILRB4, an immune checkpoint on myeloid cells
Ting Yang, Yixin Qian, Xiaoting Liang, et al.
Blood Science (2022) Vol. 4, Iss. 2, pp. 49-56
Open Access | Times Cited: 19
LILRB4 regulates the function of decidual MDSCs via the SHP-2/STAT6 pathway during Toxoplasma gondii infection
Yuantao Li, Jingjing Guo, Haixia Zhang, et al.
Parasites & Vectors (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 12
LILRB4 as a novel immunotherapeutic target for multiple diseases
Xu Wang, Lanying Li, Dan Liu, et al.
Biochemical Pharmacology (2025), pp. 116762-116762
Closed Access
Emerging Targets in Clear Cell Renal Cell Carcinoma
Yu‐Wei Chen, Brian I. Rini, Kathryn E. Beckermann
Cancers (2022) Vol. 14, Iss. 19, pp. 4843-4843
Open Access | Times Cited: 18
Myeloid checkpoints for cancer immunotherapy
Yixin Qian, Ting Yang, Huan Liang, et al.
Chinese Journal of Cancer Research (2022) Vol. 34, Iss. 5, pp. 460-482
Open Access | Times Cited: 18
Posttranslational control of lipogenesis in the tumor microenvironment
Yahui Zhu, Xingrong Lin, Xiaojun Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 16
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development
Ryan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Cancer Immunology Research (2023) Vol. 12, Iss. 3, pp. 350-362
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top